Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori urease is a large, nickel-dependent metalloenzyme complex that is essential for the survival and pathogenesis of the bacterium within the human stomach [1.1.1, 1.1.2]. It catalyzes the rapid hydrolysis of urea into ammonia and carbon dioxide, a process that neutralizes local gastric acid and creates a hospitable, near-neutral microenvironment for the acid-sensitive organism [1.1.3, 1.1.4]. This neutralization is a prerequisite for H. pylori to colonize the gastric mucosa, where it can lead to chronic inflammation, peptic ulcers, and gastric cancer [1.1.5, 1.5.4]. In addition to its enzymatic function, the protein acts as a potent immunogen and may play a non-catalytic role in protecting the bacterium from host-derived oxidative stress [1.1.5]. Due to its central role in infection, urease is the basis for gold-standard diagnostic tools like the urea breath test and is a major target for the development of novel antimicrobial therapies and vaccines [1.2.2, 1.5.1].
Inhibition of urease enzyme activity to prevent gastric acid neutralization and bacterial survival [1.2.5, 1.3.2].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urease (Helicobacter pylori) (HPU).